Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Vectura Group PLC

+ Add to Watchlist

V4T:GR

1.967 EUR 0.049 2.43%

As of 09:42:19 ET on 01/29/2015.

Snapshot for Vectura Group PLC (V4T)

Open: 2.011 Day's Range: 1.967 - 2.011 Volume: 0
Previous Close: 2.016 52wk Range: 1.389 - 2.200 1-Yr Rtn: +0.77%

Stock Chart for V4T

No chart data available.
  • V4T:GR 2.003
  • 1D
  • 1M
  • 1Y
2.016
Interactive V4T Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for V4T

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 1,477.7336
Relative P/E vs. DAX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (03/2015) 0.0010
Est. PEG Ratio -
Market Cap (M EUR) 791.67
Shares Outstanding (M) 402.48
30 Day Average Volume 303
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for V4T

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for V4T

Vectura Group PLC develops inhaled therapies for the treatment of respiratory diseases. The Company's main products are used to treat asthma and chronic obstructive pulmonary disease. Vectura also develops products for lung pathologies and non-respiratory diseases.

Christopher Paul Blackwell "Chris"CEO/Executive DirectorAndrew J OakleyCFO/Exec Dir/Secretary
Gerhard ScheuchChief Scientific OfficerKarl D KeeganChief Corporate Dev Officer
More Company Profile & Key Executives for V4T

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil